MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, PTGX made $4,712K in revenue. -$39,339K in net income. Net profit margin of -834.87%.

Income Overview

Revenue
$4,712K
Net Income
-$39,339K
Net Profit Margin
-834.87%
EPS
-$0.62
Unit: Thousand (K) dollars

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Income Statement
2025-09-30
2025-06-30
2025-03-31
2024-09-30
License and collaboration revenue
4,712 5,546 28,321 4,675
Research and development
40,003 37,036 35,893 35,970
General and administrative
11,130 10,551 11,738 10,158
Total operating expenses
51,133 47,587 47,631 46,128
(loss) income from operations
-46,421 -42,041 -19,310 -41,453
Interest income
7,049 7,406 7,573 7,682
Other income, net
33 36 82 141
(loss) income before income tax benefit (expense)
-39,339 -34,599 -11,655 -33,630
Income tax expense (benefit)
-172 --420
Net (loss) income
-39,339 -34,771 -11,655 -33,210
Earnings per share, basic
-0.62 -0.55 -0.19 -0.54
Earnings per share, diluted
-0.62 -0.55 -0.19 -0.54
Weighted average number of shares outstanding, basic
63,772,332 63,510,537 62,963,806 61,767,934
Weighted average number of shares outstanding, diluted
63,772,332 63,510,537 62,963,806 61,767,934
Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net (loss) income-$39,339K (loss) income beforeincome tax benefit...-$39,339K Other income, net$33K Interest income$7,049K (loss) income fromoperations-$46,421K License andcollaboration revenue$4,712K Total operatingexpenses$51,133K General andadministrative$11,130K Research and development$40,003K

Protagonist Therapeutics, Inc (PTGX)

Protagonist Therapeutics, Inc (PTGX)